BA

Baliopharm

Jülich, Germany

About

Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer.

Position in the VCSift Database

  • 3,884 investors in VCSift focus on the healthtech sector.
  • 2 investors are based in Jülich, Nordrhein-Westfalen, Germany.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Contact Information

ph••••@baliopharm.com

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Baliopharm

Search Investors